Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten de Wit

Showing results (151-160 of 205) with videos related to

Pageof 21
Sort By:
Annals of the Rheumatic Diseases|October 15, 2020
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working groupSabrina Mai Nielsen, Marianne Uggen Rasmussen, Maarten Boers, et al.
The Journal of Rheumatology|December 17, 2019
Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic ReviewAyano Kelly, Luke Crimston-Smith, Allison Tong, et al.
The Journal of Rheumatology|August 3, 2017
Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016Linda A Rasch, Maarten Boers, Catherine L Hill, et al.
RMD Open|May 6, 2022
Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countriesFlorian Lucasson, Uta Kiltz, Umut Kalyoncu, et al.
The Journal of Rheumatology|April 17, 2015
Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision MakingKarine Toupin-April, Jennifer Barton, Liana Fraenkel, et al.
Annals of the Rheumatic Diseases|March 3, 2016
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task forceCindy Strehl, Johannes W J Bijlsma, Maarten de Wit, et al.
Seminars in Arthritis and Rheumatism|July 19, 2021
Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group reportBethan Jones, Caroline A Flurey, Susanna Proudman, et al.
Annals of the Rheumatic Diseases|June 14, 2024
EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 updateMaarten de Wit, Krystel Aouad, Muriel Elhai, et al.
Annals of the Rheumatic Diseases|November 17, 2018
Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countriesClémence Gorlier, Ana-Maria Orbai, Déborah Puyraimond-Zemmour, et al.
Annals of the Rheumatic Diseases|May 3, 2014
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiativeLaure Gossec, Maarten de Wit, Uta Kiltz, et al.
Pageof 21

Showing results (151-160 of 205) with videos related to

Sort By:
Pageof 21
Annals of the Rheumatic Diseases|October 15, 2020
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working groupSabrina Mai Nielsen, Marianne Uggen Rasmussen, Maarten Boers, et al.
The Journal of Rheumatology|December 17, 2019
Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic ReviewAyano Kelly, Luke Crimston-Smith, Allison Tong, et al.
The Journal of Rheumatology|August 3, 2017
Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016Linda A Rasch, Maarten Boers, Catherine L Hill, et al.
RMD Open|May 6, 2022
Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countriesFlorian Lucasson, Uta Kiltz, Umut Kalyoncu, et al.
The Journal of Rheumatology|April 17, 2015
Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision MakingKarine Toupin-April, Jennifer Barton, Liana Fraenkel, et al.
Annals of the Rheumatic Diseases|March 3, 2016
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task forceCindy Strehl, Johannes W J Bijlsma, Maarten de Wit, et al.
Seminars in Arthritis and Rheumatism|July 19, 2021
Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group reportBethan Jones, Caroline A Flurey, Susanna Proudman, et al.
Annals of the Rheumatic Diseases|June 14, 2024
EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 updateMaarten de Wit, Krystel Aouad, Muriel Elhai, et al.
Annals of the Rheumatic Diseases|November 17, 2018
Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countriesClémence Gorlier, Ana-Maria Orbai, Déborah Puyraimond-Zemmour, et al.
Annals of the Rheumatic Diseases|May 3, 2014
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiativeLaure Gossec, Maarten de Wit, Uta Kiltz, et al.
Pageof 21